Back to ARNA Stock Lookup

ARNA Related Analyst Ratings

Mar 4, 2013 02:18 PM Needham Sees Strong Start for Arena's (ARNA) Belviq in U.S.; European Approval Unlikely

Mar 4, 2013 10:08 AM VIVUS (VVUS) Cuts Qsymia Price by About 70%; Arena (ARNA) on Watch

Feb 25, 2013 01:15 PM Arena (ARNA) Will Need Lower Co-Payments, Broader Coverage for Belviq Success (VVUS)

Feb 6, 2013 07:14 AM Leerink Swann Resumes Arena Pharma (ARNA) at Outperform

Feb 4, 2013 10:45 AM VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX)

Jan 17, 2013 07:41 AM Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales

Dec 21, 2012 11:56 AM JPMorgan Confident Orexigen's (OREX) Will Receive FDA Approval; Comments on Meeting

Dec 18, 2012 03:23 PM Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave

Dec 10, 2012 09:10 AM VIVUS (VVUS) Qsymia Prescriptions Pop Following Thanksgiving Glut (ARNA) (OREX)

Nov 7, 2012 11:26 AM Jefferies Remains Bullish on Arena Pharma (ARNA) But Tempers Valuation Target on Data from Rival

Oct 31, 2012 02:18 PM Latest Qsymia Data Shapes Up Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX)

Oct 26, 2012 11:58 AM VIVUS (VVUS) Qsymia Prescriptions Remain High Amid Birth Defect Warning; Positive for Arena (ARNA)

Oct 15, 2012 11:18 AM VIVUS (VVUS) Qsymia Continues to See Strong Early Demand

Oct 8, 2012 12:48 PM VIVUS' (VVUS) Qsymia Prescription Insurer Pay Rate Rose 5% in Week Two

Sep 21, 2012 12:19 PM Not Expecting E.U. Approval for Vivus' (VVUS) Qsiva, Could be a Plus for Orexigen (OREX) - Analyst

Sep 6, 2012 03:42 PM Orexigen (OREX) Surges On 'Aggressive' Buy Calls Ahead of Catalysts

Sep 6, 2012 07:19 AM Credit Suisse Starts Arena Pharma (ARNA) at Underperform

Jul 18, 2012 09:08 AM VIVUS' (VVUS) Qsymia Approved and has Advantages Over Belviq

Jul 18, 2012 08:57 AM Brean Murray Positive on Vivus (VVUS) after Approval

Jul 16, 2012 11:09 AM VIVUS (VVUS) Gets a Boost from Uber-Bullish Orexigen (OREX) Call

Jul 13, 2012 08:43 AM With Plenty of Good Arguments for Both Bulls and Bears, VIVUS (VVUS) Qnexa Approval at 50/50 - Jefferies

Jun 28, 2012 03:39 PM UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space

Jun 28, 2012 02:54 PM JPMorgan Boosts Target on Vivus (VVUS), More Confidence in Approval

Jun 28, 2012 02:44 PM JPMorgan Muted on Arena Pharma (ARNA) After Approval, Lifts Target to $11

Jun 28, 2012 10:21 AM Canaccord Genuity Morning Coffee on Arena Pharma. (ARNA): Does This Mean I Can Keep Eating Super-Sized Double Big Mac Meals?

Jun 28, 2012 07:58 AM Needham & Company on Arena Pharma (ARNA); Obese Population Large, But Poor Track Record of Drugs in the Space

Jun 28, 2012 06:51 AM Jefferies Boosts Arena (ARNA) Target to $20

Jun 25, 2012 07:18 AM BMO Capital Downgrades Arena Pharma (ARNA) to Market Perform Ahead of PDUFA

May 14, 2012 08:31 AM Jefferies Sees a 3-6 Month Delay for Arena's (ARNA) Lorcaserin But Reiterates Buy Rating

May 11, 2012 11:42 AM Leerink Still Sees VIVUS's (VVUS) Qnexa as 'Obesity Therapy of Choice'

May 11, 2012 11:23 AM Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight

May 11, 2012 10:49 AM Needham Maintains Cautious View of Arena Pharma (ARNA)

May 11, 2012 08:36 AM Leerink Swann Upgrades Arena Pharma (ARNA) to Outperform; Positive Panel Vote For Lorcaserin

May 11, 2012 07:54 AM Jefferies Upgrades Arena Pharma (ARNA) to Buy

May 9, 2012 07:25 AM BMO Capital Upgrades Arena Pharma (ARNA) to Outperform, Raises Target 600%

Apr 10, 2012 08:26 AM Vivus (VVUS) Qnexa PDUFA Delay a "Minor Hiccup" - Leerink Swann

Mar 28, 2012 10:08 AM Arena (ARNA) Shares Sink as Piper Jaffray Downgrade Weighs

Mar 28, 2012 07:12 AM Piper Jaffray Cuts Arena Pharma (ARNA) to Neutral

Mar 15, 2012 08:21 AM Jefferies Keeps Lowest Rating on Arena Pharma (ARNA) After Q4 Call and Into May Lorcaserin Panel

Mar 6, 2012 08:54 AM Editorial Suggests Possible Pre-Approval CV Testing For VIVUS' (VVUS) Qnexa, Others - Analyst

Feb 23, 2012 11:20 AM Leerink Swann: Buyers of Orexigen Therapeutics (OREX) Into Next Panel; Preferred Small/Midcap Biotech Pick

Jan 6, 2012 10:08 AM Needham & Company Maintains a 'Hold' on Arena Pharma (ARNA); Meaningful Risks to Lorcaserin Approval

Jan 4, 2012 08:38 AM Needham & Company Remains Cautious on Arena Pharma (ARNA) Given Lingering Uncertainty Around Rat Mammary Tumors; Lorcaserin NDA Resubmitted

Nov 28, 2011 07:24 AM Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight

Sep 22, 2011 10:03 AM Needham & Company Maintains a 'Hold' on Arena Pharma (ARNA); Remain Cautious on the Stock

Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform

Mar 14, 2011 01:22 PM Barclays Maintains an 'Underweight' on Arena Pharma (ARNA); Reports 4Q, Uncertainty Persists

Dec 23, 2010 10:26 AM Summer Street Upgrades Arena Pharma (ARNA) to Neutral; Some Clarity From This Week’s FDA Meeting

Nov 10, 2010 11:24 AM UBS Maintains a 'Neutral' on Arena Pharma (ARNA); BLOOM-DM: Likely Not Enough

Oct 25, 2010 11:29 AM Canaccord Genuity reiterates a 'Hold' on Arena Pharmaceuticals (ARNA); Lorcaserin CR Provides Only Very Dim Light At The End of Long Tunnel

Back to ARNA Stock Lookup